FNBT
TSRX

FineMark National Bank & Trust’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

FineMark National Bank & Trust’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-15,000
Closed -$122K – 1679
2013
Q2 		$122K Buy
+15,000
New +$111K 0.04% 362

Other funds holding TSRX

PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

FineMark National Bank & Trust's TSRX Position: Q3 2013 in Review

FineMark National Bank & Trust sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 15,000 shares — an estimated $122K sold.

FineMark National Bank & Trust first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $122K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

  • FineMark National Bank & Trust reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • FineMark National Bank & Trust sold 15,000 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $122K.
  • FineMark National Bank & Trust first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • FineMark National Bank & Trust's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $122K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on FineMark National Bank & Trust's 13F filing for Q3 2013, filed 14 Nov 2013.